Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Farrukh Awan
Observed name:
Awan, Farrukh
Institutions:
Harold C. Simmons Comprehensive Cancer Center,
The University of Texas Southwestern Medical Center
Observed institutions:
Harold C. Simmons Comprehensive Cancer Center,
The University of Texas Southwestern Medical Center
OpenAlex ID:
A5137035263
Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas
2026
·
Malak Munir
, Ahmed Sayed
, et al.
·
Journal of Hematology & Oncology
·
1
PDF
Impact of insurance status on testicular cancer outcomes: A single-institution, dual-site study
2025
·
Ifeanyi Chidera Ibezue
, Zine-Eddine Khene
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
1
Dual Immunotherapy in Aggressive Lymphoma (DIAL) study, a randomized phase 2 trial of Varlilumab in combination with Nivolumab in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
2026
·
Rafael Hennemann Sassi
, Susan Geyer
, et al.
·
Research Square
PDF
ABCL-1574: Persistent Site-Specific Excess Risk of Second Primary Malignancies Among Diffuse Large B-Cell Lymphoma Survivors: A SEER-Based Analysis From 2000 to 2022
2026
·
Imran Khan
, Shahzaib Maqbool
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-1574: Persistent Site-Specific Excess Risk of Second Primary Malignancies Among Diffuse Large B-Cell Lymphoma Survivors: A SEER-Based Analysis From 2000 to 2022
2026
·
Imran Khan
, Shahzaib Maqbool
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma
2026
·
John Behman
, Nausheen Ahmed
, et al.
·
Haematologica
PDF
Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas
2026
·
Munir, Malak
, Sayed, Ahmed
, et al.
·
Figshare
Additional file 1 of Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas
2026
·
Munir, Malak
, Sayed, Ahmed
, et al.
·
Figshare
CLO26-086: Pre-Exposure Prophylaxis With Pemivibart in Adults With Hematologic Malignancies: A Single-Center Cohort
2026
·
Truman Koh
, Ashwin Sunderraj
, et al.
·
Journal of the National Comprehensive Cancer Network
Show more works
View as search
Works count:
9
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type